In this study, we aimed to elucidate the role of m6A mRNA methylation in AD progression by conditionally inactivating the Mettl3 gene specifically in myeloid cells using a Mettl3 conditional mouse line in combination with Lyz2-Cre driver lines. Here, METTL3 is linked to Alzheimer disease.